Comments
Loading...
INmune Bio (INMB) Forecast
NewsEarningsINmune Bio (INMB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestINmune Bio (NASDAQ:INMB) Stock Quotes, Forecast and News Summary
INmune Bio Stock (NASDAQ: INMB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy INmune Bio (INMB) stock?
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
Who are INmune Bio (INMB) competitors?
Other companies in INmune Bio’s space includes: Innate Pharma (NASDAQ:IPHA), Cabaletta Bio (NASDAQ:CABA), Fate Therapeutics (NASDAQ:FATE), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).
What is the forecast, or price target, for INmune Bio (INMB) stock?
INmune Bio has a consensus price target of $16.17.
What is the current price for INmune Bio (INMB)?
The stock price for INmune Bio (NASDAQ: INMB) is $6.5201 last updated January 22, 2025 at 8:04 AM EST.
Does INmune Bio (INMB) pay a dividend?
There are no upcoming dividends for INmune Bio.
When is INmune Bio (NASDAQ:INMB) reporting earnings?
INmune Bio’s Q4 earnings are confirmed for Thursday, March 27, 2025.
Is INmune Bio (INMB) going to split?
There is no upcoming split for INmune Bio.
What sector and industry does INmune Bio (INMB) operate in?
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.